Investigation Overview
An investigation on behalf of investors of ZymoGenetics, Inc. (NASDAQ:ZGEN) over potential breaches of fiduciary duty by the ZGEN board of directors in connection with the proposed takeover of ZymoGenetics by Bristol-Myers Squibb Company was announced. The investigation by a law firm concerns whether ZymoGenetics, Inc. (NASDAQ:ZGEN and its Board breached their fiduciary duties in con...
You must register (for free) or login to view the entire investigation.